ZEHVSENZ — 2414506
Application number
2414506
Type(s)
Standard Characters
Category
Trademark
CIPO Status
APPROVED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2025-07-29
Applicant
Pfizer Inc.
66 Hudson Boulevard East
New York, NY 10001-2192
UNITED STATES OF AMERICA
Agent
TORYS LLP
SUITE 3000
79 WELLINGTON ST. W.
BOX 270, TD CENTRE
TORONTO
ONTARIO M5K1N2
Documents
Index headings
- ZEHVSENZ
Goods (Nice class & Statement)
- 5
- (1) Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory pharmaceutical preparations; Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of hematological diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; Pharmaceutical preparations for the treatment of autonomic nerve disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of arthritis; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; Pharmaceutical preparations for treatment of autoimmune diseases and disorders; Pharmaceutical preparations for use in the treatment of immunological disorders; Pharmaceutical preparations for the treatment of dermatological diseases and disorders; Pharmaceutical preparations for the treatment of dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata; Pharmaceutical preparations for the treatment of dermatitis, eczema, skin pigmentation diseases and psoriasis; Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; Pharmaceutical preparations for the treatment and management of vasomotor symptoms and symptoms associated with menopause; Pharmaceutical preparations for the treatment of obesity; Pharmaceutical preparations for the treatment of migraine; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for treating opioid overdoses; Human vaccine preparations
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2025-07-29 | ||
| Created | 2025-07-29 | ||
| Formalized | 2025-07-29 | ||
| Pre-Assessment Letter Sent | 2025-08-14 | Goods or Services Not Acceptable | |
| Search Recorded | 2026-05-11 | ||
| Approved | 2026-05-20 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2026-05-20 | APPROVED BY PROGRAM EX200M1 |